Target intelligence / Profile preview

Helicase

Molecular classification
Enzyme, Molecular motor, ATPase
01

Overview

Helicases are a diverse class of essential molecular motor enzymes that utilize energy derived from ATP hydrolysis to separate or remodel nucleic acid duplexes. They are classified into six major superfamilies (SF1–SF6) and are integral to nearly every process involving DNA and RNA, including replication, repair, transcription, and translation initiation (e.g., eIF4A). In many diseases, specific helicases are either overexpressed to support rapid cellular proliferation or are essential for the replication of viral pathogens. Therapeutic interest in helicases has surged, particularly with the discovery of synthetic lethal relationships in oncology. For instance, the Werner syndrome helicase (WRN) has been identified as a critical target for tumors with microsatellite instability (MSI-H), leading to the clinical development of inhibitors like HRO761 and VVD-214 that induce lethal DNA damage in these specific cancer cells. Furthermore, helicase-primase inhibitors such as amenamevir have reached clinical approval for treating herpes simplex virus infections, highlighting the success of targeting this enzyme class in infectious diseases. Drug mechanisms vary widely, including allosteric locking of the enzyme in an inactive state and the interfacial trapping of helicases on DNA to create cytotoxic complexes.

Other names
DNA helicaseRNA helicaseNucleoside triphosphate-dependent helicaseMolecular motorSuperfamily 1-6 (SF1-SF6) helicase
02

Mechanism of action

Allosteric inhibition, ATP-competitive inhibition, Interfacial trapping of the enzyme on nucleic acids, and direct inhibition of nucleic acid unwinding activity.

03

Biological functions

DNA replicationDNA repairTranscriptionTranslation initiationRNA processingRibosome biogenesisGenome maintenanceHomologous recombination
04

Disease associations

CancerViral infectionBacterial infectionGenetic disorders (e.g., Werner Syndrome, Bloom Syndrome, Rothmund-Thomson Syndrome)
05

Safety considerations

Gastrointestinal toxicity (e.g., nausea and vomiting)Off-target inhibition of essential host helicasesPotential for genomic instability in non-target cellsDrug resistance in viral applications
06

Interacting drugs

Amenamevir

9 more in the full profile.

07

Biomarkers

Microsatellite instability-high (MSI-H)Mismatch repair deficiency (dMMR)p53 statusViral load (e.g., for HCV/HSV targets)

Beyond the preview

Go deeper on Helicase.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Helicase.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call